These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29096549)

  • 1. Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.
    Ibraheim H; Giacomini C; Kassam Z; Dazzi F; Powell N
    Expert Rev Gastroenterol Hepatol; 2018 Feb; 12(2):141-153. PubMed ID: 29096549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
    Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
    Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis.
    Cao Y; Ding Z; Han C; Shi H; Cui L; Lin R
    Dig Dis Sci; 2017 Apr; 62(4):851-860. PubMed ID: 28168575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn's disease - review of pathomechanism and existing clinical data.
    Bor R; Fábián A; Farkas K; Molnár T; Szepes Z
    Expert Opin Biol Ther; 2018 Jul; 18(7):737-745. PubMed ID: 29939815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.
    Duijvestein M; Vos AC; Roelofs H; Wildenberg ME; Wendrich BB; Verspaget HW; Kooy-Winkelaar EM; Koning F; Zwaginga JJ; Fidder HH; Verhaar AP; Fibbe WE; van den Brink GR; Hommes DW
    Gut; 2010 Dec; 59(12):1662-9. PubMed ID: 20921206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
    Forbes GM; Sturm MJ; Leong RW; Sparrow MP; Segarajasingam D; Cummins AG; Phillips M; Herrmann RP
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):64-71. PubMed ID: 23872668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases.
    Grégoire C; Lechanteur C; Briquet A; Baudoux É; Baron F; Louis E; Beguin Y
    Aliment Pharmacol Ther; 2017 Jan; 45(2):205-221. PubMed ID: 27878827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stem Cells to Treat Crohn's Disease with Fistula.
    Zhang XM; Zhang YJ; Wang W; Wei YQ; Deng HX
    Hum Gene Ther; 2017 Jul; 28(7):534-540. PubMed ID: 28132518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell therapy for perianal Crohn's.
    Lightner AL
    Curr Opin Gastroenterol; 2019 Jul; 35(4):311-320. PubMed ID: 33216484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem/stromal cell therapy for inflammatory bowel disease: an updated review with maintenance of remission.
    Dave M; Jaiswal P; Cominelli F
    Curr Opin Gastroenterol; 2017 Jan; 33(1):59-68. PubMed ID: 28134690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis.
    Cheng F; Huang Z; Li Z
    Tech Coloproctol; 2019 Jul; 23(7):613-623. PubMed ID: 31286287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review.
    Ko JZ; Johnson S; Dave M
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33440772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remestemcel-L: human mesenchymal stem cells as an emerging therapy for Crohn's disease.
    Mannon PJ
    Expert Opin Biol Ther; 2011 Sep; 11(9):1249-56. PubMed ID: 21787241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with Crohn's disease.
    Taddio A; Tommasini A; Valencic E; Biagi E; Decorti G; De Iudicibus S; Cuzzoni E; Gaipa G; Badolato R; Prandini A; Biondi A; Ventura A
    World J Gastroenterol; 2015 Apr; 21(14):4379-84. PubMed ID: 25892890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of stem cell therapy for Crohn's disease.
    Dryden GW
    Expert Opin Biol Ther; 2009 Jul; 9(7):841-7. PubMed ID: 19527107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.
    Molendijk I; Bonsing BA; Roelofs H; Peeters KC; Wasser MN; Dijkstra G; van der Woude CJ; Duijvestein M; Veenendaal RA; Zwaginga JJ; Verspaget HW; Fibbe WE; van der Meulen-de Jong AE; Hommes DW
    Gastroenterology; 2015 Oct; 149(4):918-27.e6. PubMed ID: 26116801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease.
    Lian L; Huang Q; Zhang L; Qin H; He X; He X; Ke J; Xie M; Lan P
    Dig Dis Sci; 2018 Jul; 63(7):1821-1834. PubMed ID: 29704139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cell therapy for Crohn's disease.
    Liew A; O'Brien T; Egan L
    Dig Dis; 2014; 32 Suppl 1():50-60. PubMed ID: 25531353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell treatment for Crohn's disease.
    Panés J; Ordás I; Ricart E
    Expert Rev Clin Immunol; 2010 Jul; 6(4):597-605. PubMed ID: 20594133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stromal Cell Therapy in the Management of Perianal Fistulas in Crohn's Disease: An Up-To-Date Review.
    Gallo G; Tiesi V; Fulginiti S; De Paola G; Vescio G; Sammarco G
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33121049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.